Logo do repositório
 
Publicação

Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugal

dc.contributor.authorCurado, Adriana
dc.contributor.authorNogueira, Paulo Jorge
dc.contributor.authorVirgolino, Ana
dc.contributor.authorSanta Maria, João
dc.contributor.authorMendão, Luís
dc.contributor.authorFurtado, Cristina
dc.contributor.authorAntunes, Francisco
dc.date.accessioned2024-09-19T11:15:15Z
dc.date.available2024-09-19T11:15:15Z
dc.date.issued2022
dc.description.abstractThe hepatitis C virus (HCV) infection is an important public health problem, affecting millions of people worldwide. People who inject drugs (PWID) are at increased risk of HCV infection due to, among other factors, widespread unsafe injecting practices, such as sharing of infected equipment or unprotected sexual practices. In Portugal, there is a lack of data regarding the proportion of infected persons through injecting drug use. This study aimed to evaluate the anti-HCV prevalence and behavioral correlates of infection in PWID attending harm reduction services in the Metropolitan Area of Lisbon, Portugal. A cross-sectional study with a purposive sample of PWID was undertaken between March 2018 and March 2020. Participants were recruited through the harm-reduction services of a nongovernmental organization. A rapid diagnostic test for anti-HCV screening was performed. Data on drug consumption history and current practices, past HCV testing, care and treatment history, and knowledge regarding hepatitis C were also collected through a questionnaire applied by trained inquirers. A total of 176 PWID participated in this study. An overall prevalence of 70.5% of anti-HCV positive in this population was found. Those with an anti-HCV positive testing result tended to start consuming at a younger age and have a higher consumption of benzodiazepines in the last 30 days. Sharing needles and other injecting material is a frequent risk behavior among this group. Also, they are more likely to have attended an opioid agonist treatment and to have undertaken previous hepatitis C and HIV tests in the past. This study represents an important effort to better understand the HCV prevalence and behavioral correlates of infection among PWID in Portugal, as well as to better estimate those in need of HCV treatment.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.3389/fpubh.2022.952909pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.26/52123
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectHepatitis Cpt_PT
dc.subjectPeople Who Inject Drugspt_PT
dc.subjectHarm reductionpt_PT
dc.titleHepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugalpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleFrontiers in Public Healthpt_PT
oaire.citation.volume10pt_PT
person.familyNameCunha Curado
person.familyNamePenim Mendão
person.givenNameAdriana
person.givenNameLuís Manuel
person.identifierAAW-2241-2021
person.identifier.ciencia-idB415-89DB-2284
person.identifier.ciencia-idAA16-B94D-A1A0
person.identifier.orcid0000-0001-6405-5586
person.identifier.orcid0000-0001-7595-4499
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationfc027ce4-6f83-4e2e-abdd-a12bd272143f
relation.isAuthorOfPublication29ca9078-add3-4e8b-a989-42af18fac73b
relation.isAuthorOfPublication.latestForDiscovery29ca9078-add3-4e8b-a989-42af18fac73b

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs.pdf
Tamanho:
272.84 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.85 KB
Formato:
Item-specific license agreed upon to submission
Descrição: